TheStreet's Jim Cramer is not a fan of Herbalife (HLF) , which reports earnings on Wednesday. 'This is a battleground,' says Cramer. 'Ackman vs. Michael Johnson. I don't like battlegrounds.' Activist investor Bill Ackman has long held a short position in Herbalife, which recently settled a case with the FTC, following a two year investigation that looked into the company's business practices.
More from Video
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.